Latest venBio Partners LLC Stock Portfolio
About venBio Partners LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, venBio Partners LLC reported an equity portfolio of $170.7 Millions as of 31 Dec, 2024.
The top stock holdings of venBio Partners LLC are PHVS, , HRMY. The fund has invested 48.2% of it's portfolio in PHARVARIS N V and 12.8% of portfolio in ALUMIS INC.
They significantly reduced their stock positions in HARMONY BIOSCIENCES HLDGS IN (HRMY) and ALUMIS INC. venBio Partners LLC opened new stock positions in LYELL IMMUNOPHARMA INC (LYEL).
The top stock holdings of venBio Partners LLC are PHVS, , HRMY. The fund has invested 48.2% of it's portfolio in PHARVARIS N V and 12.8% of portfolio in ALUMIS INC.
They significantly reduced their stock positions in HARMONY BIOSCIENCES HLDGS IN (HRMY) and ALUMIS INC. venBio Partners LLC opened new stock positions in LYELL IMMUNOPHARMA INC (LYEL).
venBio Partners LLC Annual Return Estimates Vs S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| lyell immunopharma inc | 4,545,400 |
New stocks bought by venBio Partners LLC
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| harmony biosciences hldgs in | -12.27 |
| alumis inc | -1.37 |
| acelyrin inc | -1.2 |
venBio Partners LLC reduced stake in above stock
Sold off
Sector Distribution
| Sector | % |
|---|---|
| Others | 77 |
| Healthcare | 23 |
Market Cap. Distribution
| Category | % |
|---|---|
| UNALLOCATED | 77 |
| SMALL-CAP | 13.5 |
| MICRO-CAP | 9.5 |
Stocks belong to which Index?
| Index | % |
|---|---|
| Others | 77 |
| RUSSELL 2000 | 23 |
venBio Partners LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of venBio Partners LLC
Last Reported on: 14 Feb, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| PHVS | pharvaris n v | 48.17 | 4,289,300 | 82,226,000 | unchanged | 0.00 | ||
Historical Trend of PHARVARIS N V Position Held By venBio Partners LLCWhat % of Portfolio is PHVS?:Number of PHVS shares held:Change in No. of Shares Held: | ||||||||
| alumis inc | 12.83 | 2,787,400 | 21,908,900 | reduced | -1.37 | |||
| HRMY | harmony biosciences hldgs in | 10.87 | 539,194 | 18,553,700 | reduced | -12.27 | ||
| ALXO | alx oncology hldgs inc | 9.49 | 9,699,920 | 16,198,900 | unchanged | 0.00 | ||
| artiva biotherapeutics inc | 8.97 | 1,519,970 | 15,321,300 | unchanged | 0.00 | |||
| acelyrin inc | 7.00 | 3,806,410 | 11,952,100 | reduced | -1.2 | |||
| LYEL | lyell immunopharma inc | 2.66 | 7,102,190 | 4,545,400 | new | |||
